Results 21 to 30 of about 92,751 (208)
Therapeutics and Clinical Risk Management, 2021 Agnieszka Makowka, Michal Nowicki Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, Lodz, PolandCorrespondence: Michal NowickiDepartment of Nephrology, Hypertension and Kidney Transplantation, Medical ...
Makowka A, Nowicki M
doaj
Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
Toxins, 2020 Cardiovascular (CV) disease is highly prevalent in the population with chronic kidney disease (CKD), where the risk of CV death in early stages far exceeds the risk of progression to dialysis.
Merita Rroji +2 more
doaj +1 more source
Остеопороз и остеопатии, 2018 In this article, we discuss difficulties in parathyroid localization modalities in diagnosis of primary hyperparathyroidism. Most often, superior parathyroid glands are located on the posteromedial surface of the right and left lobes of the thyroid gland,
Dmitry G. Beltsevich +4 more
doaj +1 more source
Hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients; a single center study [PDF]
Journal of Nephropathology, 2017 Background: Abnormalities in calcium, phosphorous and parathyroid hormone (PTH) metabolisms are common in dialysis patients. Reaching target levels for these serologic factors and calcium × phosphorous products is recommended to minimize cardiovascular ...
Mitra Naseri
doaj +1 more source
Biochemical Risk Factors for Kidney Stones in Diabetic Patients [PDF]
Journal of Medical and Life Science, 2019 Objective: The aim of this study is to investigate the biochemical risk factors of kidney stones in diabetes. This includes the estimation of serum and urinary creatinine (Cr), albumin (Alb), sodium (Na+), potassium (K+), magnesium (Mg++), phosphorous ...
Ahmed Hamzawy +3 more
doaj +1 more source
Sālmand, 2022 Objectives This study aims to identify the factors affecting the survival of hemodialysis patients using a two-stage survival/multivariate longitudinal modelling.
Behnoush Asadollahidehkordi +3 more
doaj
Prognostic comparison of treatment methods for femoral nonunion: A retrospective study at Shahid Beheshti Hospital, Kashan, Iran [PDF]
Archives of Trauma ResearchBackground: In selecting the most appropriate surgical intervention, femoral nonunion remains a significant challenge for orthopedic surgeons. Previous studies have not established a definitive treatment of choice.Objectives: This retrospective cohort ...
Saeed Lotfi +4 more
doaj +1 more source
, 2023 Background25-hydroxyvitamin D (25(OH)D) and potentially also 1,25-dihydroxyvitamin D (1,25(OH)2D) inhibits the synthesis of parathyroid hormone (PTH) in the chief cells of the parathyroid gland. Clinical studies showing a negative correlation between (25(
Burkhard Kleuser (248982) +6 more
core +1 more source
Novel Parathyroid Hormone (PTH) Antagonists That Bind to the Juxtamembrane Portion of the PTH/PTH-related Protein Receptor [PDF]
Journal of Biological Chemistry, 2005 Current antagonists for the parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor (PTHR) are N-terminally truncated or N-terminally modified analogs of PTH(1-34) or PTHrP(1-34) and are thought to bind predominantly to the N-terminal extracellular (N) domain of the receptor.
Naoto, Shimizu +5 more
openaire +2 more sources
CHRONIC KIDNEY DISEASE, HYPERPARATHYROIDISM AND VITAMIN D
Revista de la Sociedad Argentina de Diabetes, 2018 Secondary hyperparathyroidism is a common complication of the chronic kidney disease (CKD). The most frequent consequence of HTP2 is bone disease, but it is worth mentioning that elevated levels of PTH correlated directly with extra bone diseases.
María Jimena Soutelo
doaj +1 more source